Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 309 Carcinoma, Non-Small-Cell Lung 281 Prostatic Neoplasms 160 Colorectal Neoplasms 155 Carcinoma, Hepatocellular 144 Neoplasms 134 Leukemia, Myeloid, Acute 132 Lung Neoplasms 115 Squamous Cell Carcinoma of Head and Neck 108 Multiple Myeloma 103 Triple Negative Breast Neoplasms 102 Recurrence 99 Pancreatic Neoplasms 93 Stomach Neoplasms 92 Ovarian Neoplasms 87 Neoplasm Metastasis 87 Lymphoma, Large B-Cell, Diffuse 81 Sarcoma 70 Precursor Cell Lymphoblastic Leukemia-Lymphoma 67 Esophageal Neoplasms 67 Uterine Cervical Neoplasms 66 Melanoma 65 Brain Neoplasms 65 Rectal Neoplasms 62 Head and Neck Neoplasms 62 Glioblastoma 60 Carcinoma, Renal Cell 57 Myelodysplastic Syndromes 55 Lymphoma 55 Esophageal Squamous Cell Carcinoma 54

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × Pancreatic Cystic Neoplasm × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡